Tevogen Bio files patent for T cell vaccine targeting entire viral genome, enhancing immune response against mutations and viral infections. Tevogen Bio, a clinical-stage immunotherapy biotech company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback